Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05995483 | Experimental Study With Pretest/Posttest Groups Which the Intervention Group Have the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day(BreastSelfExam) | unknown | N/A | 76 | Eastern Mediterranean UniversityOTHER | 1 | Aug 16, 2023 | clinicaltrials |
| NCT05992441 | Awareness Scale Related To Physiotherapy After Breast Cancer: A Scale Development Study | unknown | — | 450 | Fenerbahce University |
| 1 |
| Aug 15, 2023 |
| clinicaltrials |
| NCT03961698 | Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma(MARIO-3) | unknown | Phase 2 | 91 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05981716 | Young Breast Cancer Survivors Study(YBCSS) | unknown | — | 384 | University of South CarolinaOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05985187 | Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer. | unknown | Phase 3 | 412 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Aug 14, 2023 | clinicaltrials |
| NCT04547465 | 2D Speckle-tracking Echocardiography in Chemotherapy-induced Cardiomyopathy With Cardiovascular Risk Factors | unknown | — | 300 | Gia Dinh People HospitalOTHER | 1 | Aug 8, 2023 | clinicaltrials |
| NCT05837598 | Adapting the Tumor Board Model for Mental Illness and Cancer | unknown | N/A | 30 | Massachusetts General HospitalOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05975190 | Respiratory Training and Relaxation Techniques to Improve Adjuvant Radiation Therapy in DIBH in Breast Cancer(B-REST) | unknown | N/A | 108 | Technical University of MunichOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05845138 | A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression. | unknown | Phase 1 / Phase 2 | 116 | Suzhou Suncadia Biopharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05967884 | PD-1 +/- IL-4 Inhibition in ER+ Breast Cancer | unknown | Phase 2 | 20 | Ottawa Hospital Research InstituteOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT04967352 | Predicting Chronic Pain Following Breast Surgery | unknown | — | 500 | University of California, San DiegoOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05433480 | A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer | unknown | Phase 3 | 274 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05961111 | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05921279 | Understanding CARdiac Events in Breast Cancer(UCARE) | unknown | — | 100 | National University of Ireland, Galway, IrelandOTHER | 1 | Jul 25, 2023 | clinicaltrials |
| NCT05206396 | TIL Relation to pCR After Neoadjuvant Therapy in Breast Cancer Patients | unknown | — | 270 | Ain Shams UniversityOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05932758 | Excisional Vacuum-Assisted Breast Biopsy | unknown | N/A | 300 | European Institute of OncologyOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05953909 | A Study of Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01).(ERI-Based-01) | unknown | — | 120 | Fujian Cancer HospitalOTHER_GOV | 1 | Jul 20, 2023 | clinicaltrials |
| NCT05951699 | Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy | unknown | — | 105 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jul 19, 2023 | clinicaltrials |
| NCT05953168 | T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients | unknown | Phase 2 | 69 | Fudan UniversityOTHER | 1 | Jul 19, 2023 | clinicaltrials |
| NCT05945368 | A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC | unknown | Phase 2 | 78 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT05938686 | Home_Based Digital Mindful Dance Program for Breast Cancer Cases(Dance4BC) | unknown | N/A | 104 | National Yang Ming Chiao Tung UniversityOTHER | 1 | Jul 10, 2023 | clinicaltrials |
| NCT04035590 | Seroma Reduction and Drain Free Mastectomy(SARA) | unknown | N/A | 250 | Zuyderland Medisch CentrumOTHER | 1 | Jul 7, 2023 | clinicaltrials |
| NCT05509829 | EvaLuating negAtive pressUre Wound theRapy in brEast coNserving Surgery(LAUREN) | unknown | N/A | 300 | Zuyderland Medisch CentrumOTHER | 1 | Jul 7, 2023 | clinicaltrials |
| NCT02679040 | Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and Radiotherapy(HIST-RIC) | unknown | Phase 2 | 101 | Institut Paoli-CalmettesOTHER | 1 | Jul 3, 2023 | clinicaltrials |
| NCT04928014 | Validation of a Tear-based Screening Assay for Breast Cancer | unknown | — | 205 | Namida LabINDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT05223218 | Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study | unknown | — | 500 | Namida LabINDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT05830461 | Online Psychological Care Program for Women Who Attend a Breast Clinic. | unknown | N/A | 50 | University of GuadalajaraOTHER | 1 | Jul 3, 2023 | clinicaltrials |
| NCT05927779 | Study of TFX06 in Women With Advanced Breast Cancer. | unknown | Phase 1 / Phase 2 | 74 | Zhejiang Yangli Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT01579734 | Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users(HOT) | unknown | Phase 3 | 1,884 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT03920488 | Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast Cancer(PERSONA) | unknown | — | 264 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT03939156 | Patients' Preferences for Adjuvant Endocrine Therapy in Early Breast Cancer(ELENA) | unknown | — | 450 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT04304352 | Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients(VEX) | unknown | Phase 2 | 162 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT04365803 | Histology VABB-Histology Post Surgery Pilot Project (BETTY Trial)(BETTY) | unknown | — | 22 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT05095675 | Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back(BOUNCE) | unknown | — | 660 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT04689529 | Unnecessary Mastectomy Due to False Size Prediction by Preoperative Imaging Studies in Breast Cancer(PUMP) | unknown | N/A | 360 | Seoul National University HospitalOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT05919498 | Realistic Evaluation of a Job Retention Program After Breast Cancer(RECOVA-FTRACS) | unknown | — | 215 | Hospices Civils de LyonOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT04610528 | A Window-of-opportunity Study of U3-1402, a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression(TOT-HER3) | unknown | Early Phase 1 | 80 | SOLTI Breast Cancer Research GroupOTHER | 1 | Jun 23, 2023 | clinicaltrials |
| NCT05917444 | Managing Breast Cancer Treatment: Dyad's Perspectives on Treatment Decision, Financial and Family Burden. | unknown | — | 224 | National Taiwan University HospitalOTHER | 1 | Jun 23, 2023 | clinicaltrials |
| NCT05911867 | Muscle Energy Technique and Mulligan's Mobilization in Breast Cancer Surgery Patients(MWMMET) | unknown | N/A | 108 | Cairo UniversityOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05914168 | Clinical Data Collection in Breast Tomosynthesis (COBRIS)(COBRIS) | unknown | N/A | 150 | GE HealthcareINDUSTRY | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05914402 | Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PET(NeoaPET) | unknown | N/A | 100 | Fudan UniversityOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05914415 | The Effect of Preoperative Education on Postoperative Healing Quality in Patients With Mastectomy | unknown | N/A | 70 | Saglik Bilimleri UniversitesiOTHER | 0 | Jun 22, 2023 | clinicaltrials |
| NCT05914753 | Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer | unknown | N/A | 200 | Zhejiang Provincial People's HospitalOTHER | 0 | Jun 22, 2023 | clinicaltrials |
| NCT05910710 | Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer | unknown | — | 50 | Samsung Medical CenterOTHER | 1 | Jun 20, 2023 | clinicaltrials |
| NCT05726604 | 4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy(RD3D4) | unknown | N/A | 15 | Central Hospital Saint QuentinOTHER_GOV | 1 | Jun 9, 2023 | clinicaltrials |
| NCT05780307 | IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors | unknown | Phase 1 | 48 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER | 1 | Jun 7, 2023 | clinicaltrials |
| NCT05892146 | Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction | unknown | N/A | 100 | National Cheng-Kung University HospitalOTHER | 1 | Jun 7, 2023 | clinicaltrials |
| NCT05892380 | The Clinical Value of an Artificial Intelligence System Using Abbreviated Protocol of Breast MRI Facilitates Classification of Breast Lessions | unknown | — | 800 | Fudan UniversityOTHER | 1 | Jun 7, 2023 | clinicaltrials |
| NCT05760183 | Discovering Factors in Metastatic Breast Cancer Patients' Clinical Trial Experiences | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Jun 5, 2023 | clinicaltrials |
| NCT05584163 | Pilot Study to Evaluate the Prevention and Safety of Doxorubicin-induced Cardiomyopathy Using Extracorporeal Shock Waves | unknown | N/A | 72 | Ewha Womans University Mokdong HospitalOTHER | 1 | Jun 2, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Aug 16, 2023source: clinicaltrials